Cyndeo Wealth Partners LLC Grows Stake in CME Group Inc. $CME

Cyndeo Wealth Partners LLC raised its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 4.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,187 shares of the financial services provider’s stock after acquiring an additional 95 shares during the period. Cyndeo Wealth Partners LLC’s holdings in CME Group were worth $603,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. GQG Partners LLC boosted its position in shares of CME Group by 7,676.3% during the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock valued at $584,975,000 after buying an additional 2,176,685 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of CME Group by 370.5% during the first quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock valued at $704,068,000 after buying an additional 2,089,935 shares during the last quarter. Nuveen LLC purchased a new stake in shares of CME Group during the first quarter valued at $218,842,000. Alliancebernstein L.P. boosted its position in shares of CME Group by 185.5% during the first quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock valued at $330,182,000 after buying an additional 808,740 shares during the last quarter. Finally, Egerton Capital UK LLP boosted its position in shares of CME Group by 79.4% during the first quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock valued at $459,003,000 after buying an additional 765,773 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently commented on CME. Barclays dropped their price objective on CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Piper Sandler raised their target price on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Morgan Stanley raised their target price on CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 1st. JPMorgan Chase & Co. raised their target price on CME Group from $246.00 to $252.00 and gave the stock an “underweight” rating in a research report on Thursday, September 25th. Finally, Citigroup raised CME Group from a “neutral” rating to a “buy” rating and raised their target price for the stock from $275.00 to $300.00 in a research report on Thursday, September 25th. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $281.00.

Get Our Latest Stock Report on CME

Insiders Place Their Bets

In related news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the sale, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the sale, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock worth $3,527,956 over the last quarter. Company insiders own 0.30% of the company’s stock.

CME Group Stock Up 1.0%

NASDAQ CME opened at $271.45 on Friday. The stock’s 50-day moving average price is $268.89 and its 200-day moving average price is $271.17. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79. The company has a market capitalization of $97.83 billion, a P/E ratio of 26.28, a price-to-earnings-growth ratio of 5.67 and a beta of 0.41.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter last year, the company earned $2.56 earnings per share. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. On average, equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is 48.40%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.